Timothy P. Lynch, 10% Owner at AEON Biopharma, Inc. (AEON), bought 1,150,000 shares at $0.21 ($243K) on 2026-08-19, disclosed to the SEC on 2026-08-21.
10% shareholder Timothy P. Lynch purchased $243,455 worth of AEON stock at $0.21 per share, marking the largest insider purchase in the company's history. This aggressive accumulation comes as the stock has crashed nearly 77% over the last 90 days.
The stock is trading at $0.1841, down 33.25% over the last 5 days and 77.5% over the last 90 days, putting it just 2.85% above its 52-week low of $0.179.
1) FDA feedback on biosimilar development strategy from a January 2026 meeting; 2) Upcoming dividend announcement expected in May 2026; 3) The current insider buying cluster of 1 largest-ever trade serves as a momentum catalyst.
The stock is down 73.32% over the last year and currently trades at a forward P/E of -0.7684, indicating significant fundamental distress.
Something here stands out, but not much.